Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, sees markets in a "digestion phase" following the ...

Roger Altman, former deputy Treasury secretary and founder of Evercore, joins CNBC's 'Squawk Box' to discuss president-elect ...

Saudi Aramco's digital arm is in talks to take a significant minority stake in Mavenir, in a deal that is likely to value the ...

The Federal Reserve appears to be heading to a more wary and “hedged posture” on the rate and level of further rate cuts due ...

Evercore ISI initiated coverage of Edgewise Therapeutics (EWTX) with an Outperform rating and $45 price target The pipeline offers two “compelling assets” with multiple, near-term clinical readouts: ...

Evercore ISI analyst Cory Kasimov initiated coverage with a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price ...

Evercore ISI upgraded BioNTech (BNTX) to Outperform from In Line with a price target of $125, up from $110. The firm says it has been “growing increasingly constructive for some time now.” ...

is scheduled to participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, Dec. 3, 2024, ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 7th ...

We recently compiled a list of the 15 AI News You Must Read Today. In this article, we are going to take a look at where ...

Nov. 19, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in a fireside chat at the Evercore HealthCONx Conference on ...

will participate in a fireside chat at the 7th Annual Evercore HealthCONx Conference on Wednesday, December 4th, 2024 at 10:00AM Eastern Time. A live webcast of the event will be available on the ...